✦ LIBER ✦

DISSEMINATED INTRAVASCULAR COAGULATION AND INFUSION OF FACTOR-VIII-INHIBITOR BYPASSING ACTIVITY

✍ Scribed by Stenbjerg, Stener; Jrgensen, Jan

Book ID: 122955533
Publisher: The Lancet
Year: 1977
Tongue: English
Weight: 128 KB
Volume: 309
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(77)91156-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant occurrence of disseminated i

Concomitant occurrence of disseminated intravascular coagulation and factor VIII inhibitor in a patient with prostatic cancer

✍ Dr. Usha Singal; Eberhard F. Mammen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB 👁 3 views

An 86-year-old man, diagnosed as having carcinoma of the prostate, stage D, was admitted to the hospital. Soon after admission, he developed bleeding from various sites, including intravenous puncture sites and gastrointestinal and urinary tracts. A clinical diagnosis of disseminated intravascular c

Factor VIII inhibitor bypassing activity

Factor VIII inhibitor bypassing activity (FEIBA) – addressing safety issues

✍ L. M. ALEDORT 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Factor VIII Inhibitor bypassing activity

Factor VIII Inhibitor bypassing activity: A suggested mechanism of action

✍ T.W. Barrowcliffe; G. Kemball-Cook; E. Gray 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 394 KB

Acquired factor V inhibitor in a context

Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulation

✍ Anne Tessier-Marteau; Sabine Croquefer; Ferhat Meziani; Sylvain Cau; Pierre Asfa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 3 views

Plasma tissue factor and tissue factor p

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

✍ Shimura, Minori; Wada, Hideo; Wakita, Yoshihiro; Nakase, Tutomu; Hiyoyama, Katsu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 3 views

We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPI and vascular endothelial cell injury. Plasma TF (273 ± 90 pg/ml) and TFPI (252 ± 125 ng/ml) levels wer

Plasma tissue factor and tissue factor p

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

✍ Shimura, Minori; Wada, Hideo; Wakita, Yoshihiro; Nakase, Tutomu; Hiyoyama, Katsu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPl and vascular endothelial cell injury. Plasma TF (273 2 90 pg/ml) and TFPl (252 2 125 nglml) levels wer